Charité: Research year 2025 with top achievements
Charité – Universitätsmedizin Berlin can look back on an outstanding research year in 2025. Innovative projects, clinical trials and international funding successes underline its position as one of the most research-intensive medical institutions in Europe.
Highlights include the new Cluster of Excellence ImmunoPreCept, the continuation of NeuroCure, two new Collaborative Research Centers (CRCs) on fatty liver disease and chronobiology, four new ERC grants, and a top position in EU funding. Charité leads in Horizon Europe health promotion in Germany and ranks 7th in Europe.
Scientific breakthroughs include deciphering sleep regulation in fruit flies, AI-powered brain signal decoding for personalized therapies, and curing an HIV patient through stem cell transplantation. In the field of gene and cell therapy, the Berlin Center for Advanced Therapies (BeCAT) was almost completed, and the Berlin Center for Gene and Cell Therapies (BC GCT) started with a groundbreaking ceremony.
Despite reduced public funding and increasing pressure on scientists, Dean Prof. Joachim Spranger emphasizes the importance of academic freedom. 15 Charité researchers are among the world’s most cited scientists, reflecting the diversity and quality of research in areas such as immunology, neuroscience, and virology.
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.
Most read
Interview with Dr. Jakob Adler on the EU AI Act: “The evaluation of the ever-increasing amounts of data will change our view of diseases” He is considered the father of the "Digital Competence and Artificial Intelligence (AI)" section of...- World’s first shunt operation with microsurgical robotic system at the UKSH At the University Medical Center Schleswig-Holstein (UKSH), Kiel Campus, a shunt operation was perfo...
- New findings on Long COVID: Messenger substances in nasal mucosa identified as the cause A research team from the Research Center Borstel, Kiel University, the University of Lübeck and the...
